These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 11157561

  • 1. Expression of specific matrix metalloproteinases in inflammatory myopathies.
    Kieseier BC, Schneider C, Clements JM, Gearing AJ, Gold R, Toyka KV, Hartung HP.
    Brain; 2001 Feb; 124(Pt 2):341-51. PubMed ID: 11157561
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
    Agapova OA, Ricard CS, Salvador-Silva M, Hernandez MR.
    Glia; 2001 Mar 01; 33(3):205-16. PubMed ID: 11241738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle.
    Balcerzak D, Querengesser L, Dixon WT, Baracos VE.
    J Anim Sci; 2001 Jan 01; 79(1):94-107. PubMed ID: 11204721
    [Abstract] [Full Text] [Related]

  • 5. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P, Sähr H, Lehner B, Fischer C, Seebach E, Fellenberg J.
    BMC Cancer; 2016 Mar 15; 16():223. PubMed ID: 26979530
    [Abstract] [Full Text] [Related]

  • 6. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC, Dalakas MC.
    Neurology; 2000 Jan 11; 54(1):65-71. PubMed ID: 10636127
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
    Liu Z, Ivanoff A, Klominek J.
    Int J Cancer; 2001 Mar 01; 91(5):638-43. PubMed ID: 11267973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 01; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL, Catanzaro DF, Supino PG, Gupta A, Carter J, Herrold EM, Dumlao TF, Borer JS.
    Cardiology; 2009 Oct 01; 113(3):161-8. PubMed ID: 19129699
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
    Kranzhöfer A, Baker AH, George SJ, Newby AC.
    Arterioscler Thromb Vasc Biol; 1999 Feb 01; 19(2):255-65. PubMed ID: 9974405
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
    Schoser BG, Blottner D, Stuerenburg HJ.
    Acta Neurol Scand; 2002 Apr 01; 105(4):309-13. PubMed ID: 11939944
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin and steroid regulation of matrix metalloproteinases and their endogenous tissue inhibitors in the developed corpus luteum of the rhesus monkey during the menstrual cycle.
    Young KA, Stouffer RL.
    Biol Reprod; 2004 Jan 01; 70(1):244-52. PubMed ID: 13679308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.